Streetbeat News

Stock Prices

LE

In the latest quarter, 7 analysts provided ratings for Lands' End (NASDAQ:LE), with all ratings being bullish. The average 12-month price target is $17.43, up from $16.57 previously. Key analyst Eric Beder from Small Cap Consumer Research has consistently maintained a 'Buy' rating, with recent price targets ranging from $14.00 to $20.00. Despite positive analyst sentiment, Lands' End faces financial challenges, including a -7.78% decline in revenue growth, a net margin of -2.26%, and an ROE of -2.71%.

Portfolio Pulse from Benzinga Insights

August 14, 2024 | 12:00 pm

CREX

Creative Realities (NASDAQ:CREX) reported Q2 EPS of $(0.06), beating the $(0.07) estimate, and sales of $13.12M, surpassing the $12.60M estimate. This marks a significant improvement from the previous year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 12:00 pm

TOI

The Oncology Institute shares are trading lower after reporting worse-than-expected Q2 financial results. The company also reiterated its FY24 revenue guidance with a midpoint below estimates and cut its gross profit and adjusted EBITDA guidance.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 12:00 pm

SNAL

Snail shares are trading lower after the company reported worse-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:59 am

VRCA

Verrica Pharmaceuticals shares are trading higher after the company reported better-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:57 am

EDBL

Edible Garden shares are trading higher following the company's announcement of a year-over-year increase in Q2 EPS results.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:57 am

EAT

Brinker International (NYSE:EAT) reported a 12.3% increase in revenue for fiscal Q4 2024, beating estimates. However, adjusted EPS missed expectations, leading to a 15.3% drop in share price. Chili's saw a significant traffic increase, boosting overall sales. Brinker expects FY25 revenue to be in line with estimates but EPS to fall short.

Portfolio Pulse from Anusuya Lahiri

August 14, 2024 | 11:56 am

TCBP

TC BioPharm shares are trading lower after the company announced the pricing of an offering of 2 million units at $1 per unit.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:56 am

ALBT

Avalon GloboCare shares are trading higher after the company announced its Laboratory Services MSO, LLC has begun manufacturing the GeeWhiz external male catheter.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:56 am

DGLY

Digital Ally shares are trading higher after the company was granted a U.S. Patent for tracking and analysis of drivers within a fleet of vehicles.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:55 am